Regulacje i polityka gospodarcza · 13/09/2002

Licensing Agreement for P2X7 Receptor Antagonists to be Revised

A correction is being made to a prospective grant of an exclusive license for P2X7 receptor antagonists, a type of medication being developed by a pharmaceutical company, to address certain concerns and issues that have arisen during the review process.